Harbeck N, Fasching PA, Wurstlein R, Degenhardt T, et al. Significantly longer time to deterioration of quality of life due to CANKADO PRO-React eHealth support in HR+ HER2- metastatic breast cancer patients receiving palbociclib and endocrine therapy: Primary outcome analysis of the multicenter randomized A Ann Oncol 2023 May 16:S0923-7534(23)00684-1. doi: 10.1016/j.annonc.2023.
PMID: 37201751